The Food and Drug Administration is weighing a fertility procedure that involves combining the genetic material of three people to make a baby free of certain defects, a therapy that critics say is an ethical minefield and could lead to the creation of designer babies.
FDA considers fertility procedure that raises ethical questions
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.